| Literature DB >> 31712718 |
Yuma Nihashi1, Koji Umezawa2,3, Sayaka Shinji1, Yu Hamaguchi4, Hisato Kobayashi4,5, Tomohiro Kono6, Tamao Ono1,2, Hiroshi Kagami2, Tomohide Takaya7,8,9.
Abstract
Myoblasts play a central role during skeletal muscle formation and growth. Precise understanding of myoblast properties is thus indispensable for meat production. Herein, we report the cellular characteristics and gene expression profiles of primary-cultured myoblasts of layer and broiler chickens. Broiler myoblasts actively proliferated and promptly differentiated into myotubes compared to layer myoblasts, which corresponds well with the muscle phenotype of broilers. Transcriptomes of layer and broiler myoblasts during differentiation were quantified by RNA sequencing. Ontology analyses of the differentially expressed genes (DEGs) provided a series of extracellular proteins as putative markers for characterization of chicken myogenic cells. Another ontology analyses demonstrated that broiler myogenic cells are rich in cell cycle factors and muscle components. Independent of these semantic studies, principal component analysis (PCA) statistically defined two gene sets: one governing myogenic differentiation and the other segregating layers and broilers. Thirteen candidate genes were identified with a combined study of the DEGs and PCA that potentially contribute to proliferation or differentiation of chicken myoblasts. We experimentally proved that one of the candidates, enkephalin, an opioid peptide, suppresses myoblast growth. Our results present a new perspective that the opioids present in feeds may influence muscle development of domestic animals.Entities:
Mesh:
Year: 2019 PMID: 31712718 PMCID: PMC6848216 DOI: 10.1038/s41598-019-52946-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Proliferation and differentiation of chicken myoblasts. (A) Growth of chicken myoblasts in GM. *p < 0.05; **p < 0.01 (Student’s t test at each time point). n = 3. (B) EdU staining of chicken myoblasts in GM. Scale bar, 200 μm. (C) The ratio of EdU+ cells. *p < 0.05 (Student’s t test). n = 4. (D) MHC staining of chicken myoblasts in DM at day 2. Scale bar, 200 μm. (E,F) The ratio of MHC+ myocytes (E) and fusion indexes (F). *p < 0.05; **p < 0.01 vs WL at each time point (Student’s t test). n = 4.
Figure 2DEGs in chicken myoblasts. (A) Numbers of DEGs between WL and UKC myoblasts on each day. (B,C) Numbers of DEGs during differentiation of WL (B) and UKC (C) myoblasts. p < 0.05 (FDR), |fold-change| ≥ 2. (D,E) Volcano plots of the DEGs shown in (A–C).
Gene ontologies of the 336 DEGs.
| Class |
| Genes |
|---|---|---|
| Proteinaceous extracellular matrix | 7.1E-06 | |
| Extracellular matrix | 3.4E-05 | |
| Extracellular region | 7.7E-05 | |
| Extracellular space | 3.6E-04 | |
| Axon | 2.7E-03 | |
| Neuron projection | 3.4E-03 | |
| Integral component of plasma membrane | 1.0E-02 | |
| Collagen trimer | 2.7E-02 | |
| Cell surface | 3.9E-02 |
Figure 3DEGs involved in myogenic differentiation. (A) Heatmap and phylogeny of the 840 DEGs during differentiation. p < 0.05 (FDR), |fold-change| ≥ 4. (B) Ontology analysis of the 840 DEGs.
Figure 4Functional protein association networks within WG, WD, UG, and UD genes were visualized by STRING.
Figure 5Results of PCA and expression levels of the candidate genes. (A) PCA space with PC1 and PC2. Total 18 samples as presented in the legend were plotted. (B,C) Genes with significant factor loadings for PC1 (B) and PC2 (C) are listed in a descending order. The significant value of factor loadings is selected by criterion that the value is larger than μ + 5σ or smaller than μ-5σ. μ, mean value; σ, standard deviation. (D–J) RPKM values of RNA-seq as transcription levels of CCK (D), CXCL14 (E), MDK (F), PENK (G) CSRP2 (H), MFAP5 (I), and UCHL1 (J) genes. *p < 0.05; **p < 0.01 vs WL at each time point (FDR).
The 13 candidate genes.
| Category | Gene | Product | Involved in | |
|---|---|---|---|---|
| Cell cycle |
| Cyclin-dependent kinase inhibitor 2B (p15) | PC2 | 336 DEGs |
| Muscle |
| Cardiac muscle actin, alpha | PC1, PC2 | 840 DEGs |
|
| Myosin heavy chain 15 | PC1, | 840 DEGs | |
|
| Troponin I1 | PC1 | 840 DEGs | |
|
| Troponin I2 | PC1 | 840 DEGs | |
|
| Troponin T2 | PC1, PC2 | 840 DEGs | |
| Peptide, cytokine |
| Cholecystokinin | PC1, PC2 | 336 DEGs |
|
| C-X-C motif chemokine ligand 14 | PC2 | 336 DEGs | |
|
| Midkine | PC2 | 336 DEGs | |
|
| Proenkephalin | PC1 | 840 DEGs | |
| Others |
| Cysteine and glycine-rich protein 2 | PC2 | 840 DEGs |
|
| Microfibril associated protein 5 | PC2 | 336 DEGs | |
|
| Ubiquitin C-terminal hydrolase L1 | PC1 | 840 DEGs | |
Figure 6Enkephalin suppresses myoblast proliferation. (A) qPCR results of PENK gene transcription in the chicken myoblasts subjected to RNA-seq. NS, no significant difference vs WL (Student’s t test at each time point). n = 3. (B) Correlation of the chicken PENK gene transcription quantified by RNA-seq and qPCR (Pearson’s correlation coefficient test). (C,D) qPCR results of pro-enkephalin gene transcription in murine (C) and human (D) myoblasts in DM. The mean value at day 0 was set at 1.0. * p < 0.05, **p < 0.01 vs day 0 (Williams’ test). n = 3–4. (E) Growth of WL and UKC myoblasts in GM with 1 μM MENK or LENK peptide. ††p < 0.01 vs control WL; **p < 0.01 vs control UKC (Scheffe’s F test at each time point). n = 4. (F) MHC staining of WL and UKC myogenic cells in DM with 1 μM enkephalin at day 2. Scale bar, 200 μm. (G,H) The ratio of MHC+ myocytes and fusion indexes of WL (G) and UKC (H) myogenic cells. No significant difference among control, MENK, and LENK samples in each group (Scheffe’s F test). n = 4.